12th Aug 2024

First UK commercial sales of the Genedrive® CYP2C19 ID Kit

genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, is pleased to anno...

6th Aug 2024

Directorate Change

genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, announces that its...

31st Jul 2024

NICE recommends the Genedrive® CYP2C19 ID Kit in final guidance

genedrive plc (AIM: GDR), the point-of-care pharmacogenetic testing company, is pleased to anno...